decreased cardiomyocyte apoptosis_Tg(Myh6-Mapk8*,Myh6-Mapk9*)22.4Jmol/0

http://metadb.riken.jp/0003223IFVBNTgMyh6Mapk8Myh6Mapk9224Jmol0TgMyh6Mapk8Myh6Mapk9224Jmol

decreased cardiomyocyte apoptosis_Tg(Myh6-Mapk8*,Myh6-Mapk9*)22.4Jmol/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 22.4, Jeffery D Molkentin
  http://metadb.riken.jp/db/mgi_rdf/MGI:3851973

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Myh6-Mapk8*,Myh6-Mapk9*)22.4Jmol/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Myh6-Mapk8*,Myh6-Mapk9*)22.4Jmol

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased cardiomyocyte apoptosis
  http://purl.obolibrary.org/obo/MP_0003223

文献

http://purl.org/net/cito/citesAsAuthority

• Robert A. Kaiser, et.al., Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo., The Journal of biological chemistry, 2005, 280
  http://rdf.ncbi.nlm.nih.gov/pubmed/16043490